Meramec Financial Planners, LLC

Position in EXEL — Exelixis, Inc.

CIK 2100778 SAINT LOUIS, MO

Position in EXEL

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,414

New position

Shares Held

26

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#728

of 755 holders

Holding Since

Jun 2026

1 quarter on record

Healthcare · as of Jun 30, 2026

Meramec Financial Planners, LLC holds $294,828 across 5 Biotechnology names. EXEL ranks #5 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	OBIO	Orchestra BioMed Holdings, Inc.	30,000	$129,450
2	TVTX	Travere Therapeutics, Inc.	2,275	$129,242
3	VKTX	Viking Therapeutics, Inc.	585	$22,820
4	INCY	Incyte Corp	105	$11,902
5	EXEL	Exelixis, Inc. This page	26	$1,414

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,414	26	—	Shares	Sole	2026-07-29
No filing history on record for this holder in this stock.